Cargando…

Correction: Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin

Detalles Bibliográficos
Autores principales:	Bello, Ezia, Brich, Silvia, Craparotta, Ilaria, Mannarino, Laura, Ballabio, Sara, Gatta, Raffaella, Marchini, Sergio, Carrassa, Laura, Matteo, Cristina, Sanfilippo, Roberta, Gronchi, Alessandro, Casali, Paolo Giovanni, Pilotti, Silvana, D’Incalci, Maurizio, Frapolli, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109093/ https://www.ncbi.nlm.nih.gov/pubmed/32047297 http://dx.doi.org/10.1038/s41416-020-0746-5

Ejemplares similares

Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin
por: Bello, Ezia, et al.
Publicado: (2019)

Identification of a gene expression driven progression pathway in myxoid liposarcoma
por: De Cecco, Loris, et al.
Publicado: (2014)

A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma
por: Uboldi, Sarah, et al.
Publicado: (2012)

Mechanism of action of trabectedin in desmoplastic small round cell tumor cells
por: Uboldi, S., et al.
Publicado: (2017)

Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
por: Belgiovine, Cristina, et al.
Publicado: (2017)

A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia
por: Mannarino, L, et al.
Publicado: (2018)

New activities for the anti-tumor agent trabectedin: taking two birds with one stone
por: D'Incalci, Maurizio, et al.
Publicado: (2013)

Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment
por: Allavena, Paola, et al.
Publicado: (2022)

Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma
por: Chen, Mark, et al.
Publicado: (2019)

Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms
por: Romano, Michela, et al.
Publicado: (2017)

High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma
por: Colia, Vittoria, et al.
Publicado: (2017)

Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin
por: Fabbroni, Chiara, et al.
Publicado: (2021)

Tumor Calcification: A New Response Pattern of Myxoid Liposarcoma to Trabectedin
por: Turpin, Anthony, et al.
Publicado: (2014)

Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma
por: Tamiya, Hironari, et al.
Publicado: (2020)

Trabectedin as second-line treatment in metastatic myxoid liposarcoma: a case report
por: Pedrinaci, Irene Zarcos, et al.
Publicado: (2012)

Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
por: Gronchi, Alessandro, et al.
Publicado: (2019)

High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma
por: Sanfilippo, Roberta, et al.
Publicado: (2014)

Inhibition of tumor‐associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti‐PD‐1 therapy
por: Belgiovine, Cristina, et al.
Publicado: (2021)

Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib
por: Stacchiotti, Silvia, et al.
Publicado: (2012)

Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study
por: Stacchiotti, Silvia, et al.
Publicado: (2013)

Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia
por: Aquila, Giorgio, et al.
Publicado: (2020)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
por: Galmarini, Carlos M., et al.
Publicado: (2014)

Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin
por: Colmegna, B, et al.
Publicado: (2015)

Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
por: D'Incalci, M, et al.
Publicado: (2014)

Primary myxoid liposarcoma of the pelvis: An unusual location
por: Rico Gala, Susana, et al.
Publicado: (2020)

Trabectedin: A drug from the sea that strikes tumor-associated macrophages
por: Allavena, Paola, et al.
Publicado: (2013)

Aggressive myxoid liposarcoma of mediastinum.
por: Sharma, B. S., et al.
Publicado: (1992)

Retroperitoneal perirenal myxoid liposarcoma
por: Crisan, Nicolae, et al.
Publicado: (2015)

Primary Retroperitoneal Myxoid Liposarcomas
por: Setsu, Nokitaka, et al.
Publicado: (2016)

Recurrent myxoid liposarcoma of the hand
por: Boyd, Carter J., et al.
Publicado: (2019)

Management of myxoid liposarcoma of the extremity
por: Tfayli, Yehia, et al.
Publicado: (2021)

Primary Orbital Myxoid Liposarcoma
por: Benavides-Huerto, Miguel Armando, et al.
Publicado: (2023)

HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance
por: Loria, Rossella, et al.
Publicado: (2018)

Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives
por: Zambelli, Alberto, et al.
Publicado: (2023)

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma
por: Gadducci, Angiolo, et al.
Publicado: (2018)

Subcutaneous Myxoid and Round Cell Liposarcoma
por: Roh, Hyun Soo, et al.
Publicado: (2011)

Imaging of Skeletal Metastases in Myxoid Liposarcoma
por: Noble, J. L., et al.
Publicado: (2010)

Primary myxoid liposarcoma of the supraglottic larynx
por: Gleinser, David M, et al.
Publicado: (2010)

Myxoid liposarcoma: it's a hippo's world
por: Regina, Carla, et al.
Publicado: (2019)

Prognostic factors of metastatic myxoid liposarcoma
por: Shinoda, Yusuke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r4a2q5bh1b09lthi3bv337mnuh